APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Integrin Alpha V

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Integrin Alpha V Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174003680319 December 2025185 pages

Choose your research edition.

Industry ResearchIntegrin Alpha V Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrin Alpha V Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Integrin Alpha V Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrin Alpha V Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrin Alpha V Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Integrin Alpha V market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Integrin Alpha V include Merck & Co Inc, Biogen Inc, Vascular Pharmaceuticals Inc, SciFluor Life Sciences LLC, Morphic Therapeutic Inc, Merck KGaA, MedImmune LLC, Factor Therapeutics Ltd and BioMAS Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Integrin Alpha V market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Integrin Alpha V and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Integrin Alpha V revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Integrin Alpha V market size, projected growth trends, production technologies, key applications, and end-use industries.

Integrin Alpha V Segment by Company

Merck & Co Inc

Biogen Inc

Vascular Pharmaceuticals Inc

SciFluor Life Sciences LLC

Morphic Therapeutic Inc

Merck KGaA

MedImmune LLC

Factor Therapeutics Ltd

BioMAS Ltd

Integrin Alpha V Segment by Type

MK-0429

C-16Y

AC-301

264-RAD

Others

Integrin Alpha V Segment by Application

Ophthalmology

Respiratory

Metabolic Disorders

Infectious Disease

Others

Integrin Alpha V Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Alpha V market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrin Alpha V and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Alpha V.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Integrin Alpha V in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Integrin Alpha V industry.

Chapter 3: Detailed analysis of Integrin Alpha V companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Integrin Alpha Vrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Integrin Alpha V Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of MK-0429 Table 3. Key Players of C-16Y Table 4. Key Players of AC-301 Table 3. Key Players of 264-RAD Table 4. Key Players of Others Table 5. Global Integrin Alpha V Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Ophthalmology Table 7. Key Players of Respiratory Table 8. Key Players of Metabolic Disorders Table 9. Key Players of Infectious Disease Table 10. Key Players of Others Table 11. Global Integrin Alpha V Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Integrin Alpha V Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Integrin Alpha V Market Share by Region (2021-2026) Table 14. Global Integrin Alpha V Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Integrin Alpha V Market Share by Region (2027-2032) Table 16. Integrin Alpha V Industry Trends Table 17. Integrin Alpha V Industry Drivers Table 18. Integrin Alpha V Industry Opportunities and Challenges Table 19. Integrin Alpha V Industry Restraints Table 20. Global Integrin Alpha V Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Integrin Alpha V Revenue Market Share by Company (2021-2026) Table 22. Global Integrin Alpha V Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Integrin Alpha V Key Company Head Office and Area Served Table 24. Global Integrin Alpha V Company, Product Type & Application Table 25. Global Integrin Alpha V Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Integrin Alpha V by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Integrin Alpha V Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Integrin Alpha V Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Integrin Alpha V Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Integrin Alpha V Revenue Market Share by Type (2021-2026) Table 32. Global Integrin Alpha V Revenue Market Share by Type (2027-2032) Table 33. Global Integrin Alpha V Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Integrin Alpha V Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Integrin Alpha V Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Integrin Alpha V Revenue Market Share by Application (2021-2026) Table 37. Global Integrin Alpha V Revenue Market Share by Application (2027-2032) Table 38. Merck & Co Inc Company Information Table 39. Merck & Co Inc Business Overview Table 40. Merck & Co Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Merck & Co Inc Integrin Alpha V Product Portfolio Table 42. Merck & Co Inc Recent Development Table 43. Biogen Inc Company Information Table 44. Biogen Inc Business Overview Table 45. Biogen Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Biogen Inc Integrin Alpha V Product Portfolio Table 47. Biogen Inc Recent Development Table 48. Vascular Pharmaceuticals Inc Company Information Table 49. Vascular Pharmaceuticals Inc Business Overview Table 50. Vascular Pharmaceuticals Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Vascular Pharmaceuticals Inc Integrin Alpha V Product Portfolio Table 52. Vascular Pharmaceuticals Inc Recent Development Table 53. SciFluor Life Sciences LLC Company Information Table 54. SciFluor Life Sciences LLC Business Overview Table 55. SciFluor Life Sciences LLC Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. SciFluor Life Sciences LLC Integrin Alpha V Product Portfolio Table 57. SciFluor Life Sciences LLC Recent Development Table 58. Morphic Therapeutic Inc Company Information Table 59. Morphic Therapeutic Inc Business Overview Table 60. Morphic Therapeutic Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Morphic Therapeutic Inc Integrin Alpha V Product Portfolio Table 62. Morphic Therapeutic Inc Recent Development Table 63. Merck KGaA Company Information Table 64. Merck KGaA Business Overview Table 65. Merck KGaA Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Merck KGaA Integrin Alpha V Product Portfolio Table 67. Merck KGaA Recent Development Table 68. MedImmune LLC Company Information Table 69. MedImmune LLC Business Overview Table 70. MedImmune LLC Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. MedImmune LLC Integrin Alpha V Product Portfolio Table 72. MedImmune LLC Recent Development Table 73. Factor Therapeutics Ltd Company Information Table 74. Factor Therapeutics Ltd Business Overview Table 75. Factor Therapeutics Ltd Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Factor Therapeutics Ltd Integrin Alpha V Product Portfolio Table 77. Factor Therapeutics Ltd Recent Development Table 78. BioMAS Ltd Company Information Table 79. BioMAS Ltd Business Overview Table 80. BioMAS Ltd Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. BioMAS Ltd Integrin Alpha V Product Portfolio Table 82. BioMAS Ltd Recent Development Table 83. North America Integrin Alpha V Market Size by Type (2021-2026) & (US$ Million) Table 84. North America Integrin Alpha V Market Size by Type (2027-2032) & (US$ Million) Table 85. North America Integrin Alpha V Market Size by Application (2021-2026) & (US$ Million) Table 86. North America Integrin Alpha V Market Size by Application (2027-2032) & (US$ Million) Table 87. North America Integrin Alpha V Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. North America Integrin Alpha V Market Size by Country (2021-2026) Table 89. North America Integrin Alpha V Market Size by Country (2027-2032) Table 90. Europe Integrin Alpha V Market Size by Type (2021-2026) & (US$ Million) Table 91. Europe Integrin Alpha V Market Size by Type (2027-2032) & (US$ Million) Table 92. Europe Integrin Alpha V Market Size by Application (2021-2026) & (US$ Million) Table 93. Europe Integrin Alpha V Market Size by Application (2027-2032) & (US$ Million) Table 94. Europe Integrin Alpha V Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Europe Integrin Alpha V Market Size by Country (2021-2026) Table 96. Europe Integrin Alpha V Market Size by Country (2027-2032) Table 97. China Integrin Alpha V Market Size by Type (2021-2026) & (US$ Million) Table 98. China Integrin Alpha V Market Size by Type (2027-2032) & (US$ Million) Table 99. China Integrin Alpha V Market Size by Application (2021-2026) & (US$ Million) Table 100. China Integrin Alpha V Market Size by Application (2027-2032) & (US$ Million) Table 101. Asia Integrin Alpha V Market Size by Type (2021-2026) & (US$ Million) Table 102. Asia Integrin Alpha V Market Size by Type (2027-2032) & (US$ Million) Table 103. Asia Integrin Alpha V Market Size by Application (2021-2026) & (US$ Million) Table 104. Asia Integrin Alpha V Market Size by Application (2027-2032) & (US$ Million) Table 105. Asia Integrin Alpha V Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Asia Integrin Alpha V Market Size by Country (2021-2026) Table 107. Asia Integrin Alpha V Market Size by Country (2027-2032) Table 108. South America, Middle East & Africa Integrin Alpha V Market Size by Type (2021-2026) & (US$ Million) Table 109. South America, Middle East & Africa Integrin Alpha V Market Size by Type (2027-2032) & (US$ Million) Table 110. South America, Middle East & Africa Integrin Alpha V Market Size by Application (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Integrin Alpha V Market Size by Application (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Integrin Alpha V Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. South America, Middle East & Africa Integrin Alpha V Market Size by Country (2021-2026) Table 114. South America, Middle East & Africa Integrin Alpha V Market Size by Country (2027-2032) Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Integrin Alpha V Product Image Figure 2. Global Integrin Alpha V Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Integrin Alpha V Market Share by Type: 2025 VS 2032 Figure 4. MK-0429 Image Figure 5. C-16Y Image Figure 6. AC-301 Image Figure 7. 264-RAD Image Figure 8. Others Image Figure 9. Global Integrin Alpha V Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Integrin Alpha V Market Share by Application: 2025 VS 2032 Figure 11. Ophthalmology Image Figure 12. Respiratory Image Figure 13. Metabolic Disorders Image Figure 14. Infectious Disease Image Figure 15. Others Image Figure 16. Global Integrin Alpha V Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 18. Global Integrin Alpha V Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Integrin Alpha V Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Integrin Alpha V Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Integrin Alpha V Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Integrin Alpha V Revenue Market Share by Type (2021-2032) Figure 25. Global Integrin Alpha V Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Integrin Alpha V Revenue Market Share by Application (2021-2032) Figure 27. North America Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 28. North America Integrin Alpha V Market Share by Type (2021-2032) Figure 29. North America Integrin Alpha V Market Share by Application (2021-2032) Figure 30. North America Integrin Alpha V Market Share by Country (2021-2032) Figure 31. United States Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 32. Canada Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 34. Europe Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 35. Europe Integrin Alpha V Market Share by Type (2021-2032) Figure 36. Europe Integrin Alpha V Market Share by Application (2021-2032) Figure 37. Europe Integrin Alpha V Market Share by Country (2021-2032) Figure 38. Germany Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 39. France Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 41. Italy Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 42. Russia Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 44. China Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 45. China Integrin Alpha V Market Share by Type (2021-2032) Figure 46. China Integrin Alpha V Market Share by Application (2021-2032) Figure 47. Asia Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 48. Asia Integrin Alpha V Market Share by Type (2021-2032) Figure 49. Asia Integrin Alpha V Market Share by Application (2021-2032) Figure 50. Asia Integrin Alpha V Market Share by Country (2021-2032) Figure 51. Japan Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 55. India Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 56. Australia Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Integrin Alpha V Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Integrin Alpha V Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Integrin Alpha V Market Share by Country (2021-2032) Figure 61. Brazil Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 66. UAE Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 68. Chile Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • MK-0429
  • C-16Y
  • AC-301
  • 264-RAD
  • Others
Applications
  • Ophthalmology
  • Respiratory
  • Metabolic Disorders
  • Infectious Disease
  • Others
Companies covered
  • Merck & Co Inc
  • Biogen Inc
  • Vascular Pharmaceuticals Inc
  • SciFluor Life Sciences LLC
  • Morphic Therapeutic Inc
  • Merck KGaA
  • MedImmune LLC
  • Factor Therapeutics Ltd
  • BioMAS Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Integrin Alpha V Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 MK-0429
  5. 1.2.3 C-16Y
  6. 1.2.4 AC-301
  7. 1.2.5 264-RAD
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Integrin Alpha V Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Ophthalmology
  12. 1.3.3 Respiratory
  13. 1.3.4 Metabolic Disorders
  14. 1.3.5 Infectious Disease
  15. 1.3.6 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Integrin Alpha V Growth Trends by Region
  18. 1.5.1 Global Integrin Alpha V Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Integrin Alpha V Market Size by Region (2021-2026)
  20. 1.5.3 Integrin Alpha V Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Integrin Alpha V Market Dynamics
  1. 2.1 Integrin Alpha V Industry Trends
  2. 2.2 Integrin Alpha V Industry Drivers
  3. 2.3 Integrin Alpha V Industry Opportunities and Challenges
  4. 2.4 Integrin Alpha V Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Integrin Alpha V Revenue by Company (2021-2026)
  2. 3.2 Global Integrin Alpha V Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Integrin Alpha V Key Company Head office and Area Served
  4. 3.4 Global Integrin Alpha V Company, Product Type & Application
  5. 3.5 Global Integrin Alpha V Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Integrin Alpha V Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Integrin Alpha V Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Integrin Alpha V Tier 1, Tier 2, and Tier 3
4 Integrin Alpha V Market by Type
  1. 4.1 Global Integrin Alpha V Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Integrin Alpha V Market Size by Type (2021-2032)
  3. 4.3 Global Integrin Alpha V Market Size Share by Type (2021-2032)
5 Integrin Alpha V Market by Application
  1. 5.1 Global Integrin Alpha V Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Integrin Alpha V Market Size by Application (2021-2032)
  3. 5.3 Global Integrin Alpha V Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck & Co Inc
  2. 6.1.1 Merck & Co Inc Company Information
  3. 6.1.2 Merck & Co Inc Business Overview
  4. 6.1.3 Merck & Co Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck & Co Inc Integrin Alpha V Product Portfolio
  6. 6.1.5 Merck & Co Inc Recent Developments
  7. 6.2 Biogen Inc
  8. 6.2.1 Biogen Inc Company Information
  9. 6.2.2 Biogen Inc Business Overview
  10. 6.2.3 Biogen Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Biogen Inc Integrin Alpha V Product Portfolio
  12. 6.2.5 Biogen Inc Recent Developments
  13. 6.3 Vascular Pharmaceuticals Inc
  14. 6.3.1 Vascular Pharmaceuticals Inc Company Information
  15. 6.3.2 Vascular Pharmaceuticals Inc Business Overview
  16. 6.3.3 Vascular Pharmaceuticals Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Vascular Pharmaceuticals Inc Integrin Alpha V Product Portfolio
  18. 6.3.5 Vascular Pharmaceuticals Inc Recent Developments
  19. 6.4 SciFluor Life Sciences LLC
  20. 6.4.1 SciFluor Life Sciences LLC Company Information
  21. 6.4.2 SciFluor Life Sciences LLC Business Overview
  22. 6.4.3 SciFluor Life Sciences LLC Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 SciFluor Life Sciences LLC Integrin Alpha V Product Portfolio
  24. 6.4.5 SciFluor Life Sciences LLC Recent Developments
  25. 6.5 Morphic Therapeutic Inc
  26. 6.5.1 Morphic Therapeutic Inc Company Information
  27. 6.5.2 Morphic Therapeutic Inc Business Overview
  28. 6.5.3 Morphic Therapeutic Inc Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Morphic Therapeutic Inc Integrin Alpha V Product Portfolio
  30. 6.5.5 Morphic Therapeutic Inc Recent Developments
  31. 6.6 Merck KGaA
  32. 6.6.1 Merck KGaA Company Information
  33. 6.6.2 Merck KGaA Business Overview
  34. 6.6.3 Merck KGaA Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck KGaA Integrin Alpha V Product Portfolio
  36. 6.6.5 Merck KGaA Recent Developments
  37. 6.7 MedImmune LLC
  38. 6.7.1 MedImmune LLC Company Information
  39. 6.7.2 MedImmune LLC Business Overview
  40. 6.7.3 MedImmune LLC Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 MedImmune LLC Integrin Alpha V Product Portfolio
  42. 6.7.5 MedImmune LLC Recent Developments
  43. 6.8 Factor Therapeutics Ltd
  44. 6.8.1 Factor Therapeutics Ltd Company Information
  45. 6.8.2 Factor Therapeutics Ltd Business Overview
  46. 6.8.3 Factor Therapeutics Ltd Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Factor Therapeutics Ltd Integrin Alpha V Product Portfolio
  48. 6.8.5 Factor Therapeutics Ltd Recent Developments
  49. 6.9 BioMAS Ltd
  50. 6.9.1 BioMAS Ltd Company Information
  51. 6.9.2 BioMAS Ltd Business Overview
  52. 6.9.3 BioMAS Ltd Integrin Alpha V Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 BioMAS Ltd Integrin Alpha V Product Portfolio
  54. 6.9.5 BioMAS Ltd Recent Developments
7 North America
  1. 7.1 North America Integrin Alpha V Market Size (2021-2032)
  2. 7.2 North America Integrin Alpha V Market Size by Type
  3. 7.2.1 North America Integrin Alpha V Market Size by Type (2021-2026)
  4. 7.2.2 North America Integrin Alpha V Market Size by Type (2027-2032)
  5. 7.2.3 North America Integrin Alpha V Market Share by Type (2021-2032)
  6. 7.3 North America Integrin Alpha V Market Size by Application
  7. 7.3.1 North America Integrin Alpha V Market Size by Application (2021-2026)
  8. 7.3.2 North America Integrin Alpha V Market Size by Application (2027-2032)
  9. 7.3.3 North America Integrin Alpha V Market Share by Application (2021-2032)
  10. 7.4 North America Integrin Alpha V Market Size by Country
  11. 7.4.1 North America Integrin Alpha V Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Integrin Alpha V Market Size by Country (2021-2026)
  13. 7.4.3 North America Integrin Alpha V Market Size by Country (2027-2032)
  14. 7.4.4 North America Integrin Alpha V Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Integrin Alpha V Market Size (2021-2032)
  2. 8.2 Europe Integrin Alpha V Market Size by Type
  3. 8.2.1 Europe Integrin Alpha V Market Size by Type (2021-2026)
  4. 8.2.2 Europe Integrin Alpha V Market Size by Type (2027-2032)
  5. 8.2.3 Europe Integrin Alpha V Market Share by Type (2021-2032)
  6. 8.3 Europe Integrin Alpha V Market Size by Application
  7. 8.3.1 Europe Integrin Alpha V Market Size by Application (2021-2026)
  8. 8.3.2 Europe Integrin Alpha V Market Size by Application (2027-2032)
  9. 8.3.3 Europe Integrin Alpha V Market Share by Application (2021-2032)
  10. 8.4 Europe Integrin Alpha V Market Size by Country
  11. 8.4.1 Europe Integrin Alpha V Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Integrin Alpha V Market Size by Country (2021-2026)
  13. 8.4.3 Europe Integrin Alpha V Market Size by Country (2027-2032)
  14. 8.4.4 Europe Integrin Alpha V Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Integrin Alpha V Market Size (2021-2032)
  2. 9.2 China Integrin Alpha V Market Size by Type
  3. 9.2.1 China Integrin Alpha V Market Size by Type (2021-2026)
  4. 9.2.2 China Integrin Alpha V Market Size by Type (2027-2032)
  5. 9.2.3 China Integrin Alpha V Market Share by Type (2021-2032)
  6. 9.3 China Integrin Alpha V Market Size by Application
  7. 9.3.1 China Integrin Alpha V Market Size by Application (2021-2026)
  8. 9.3.2 China Integrin Alpha V Market Size by Application (2027-2032)
  9. 9.3.3 China Integrin Alpha V Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Integrin Alpha V Market Size (2021-2032)
  2. 10.2 Asia Integrin Alpha V Market Size by Type
  3. 10.2.1 Asia Integrin Alpha V Market Size by Type (2021-2026)
  4. 10.2.2 Asia Integrin Alpha V Market Size by Type (2027-2032)
  5. 10.2.3 Asia Integrin Alpha V Market Share by Type (2021-2032)
  6. 10.3 Asia Integrin Alpha V Market Size by Application
  7. 10.3.1 Asia Integrin Alpha V Market Size by Application (2021-2026)
  8. 10.3.2 Asia Integrin Alpha V Market Size by Application (2027-2032)
  9. 10.3.3 Asia Integrin Alpha V Market Share by Application (2021-2032)
  10. 10.4 Asia Integrin Alpha V Market Size by Country
  11. 10.4.1 Asia Integrin Alpha V Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Integrin Alpha V Market Size by Country (2021-2026)
  13. 10.4.3 Asia Integrin Alpha V Market Size by Country (2027-2032)
  14. 10.4.4 Asia Integrin Alpha V Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Integrin Alpha V Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Integrin Alpha V Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Integrin Alpha V Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Integrin Alpha V Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Integrin Alpha V Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Integrin Alpha V Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Integrin Alpha V Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Integrin Alpha V Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Integrin Alpha V Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Integrin Alpha V Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Integrin Alpha V Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Integrin Alpha V Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Integrin Alpha V Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Integrin Alpha V Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst